CHARACTERIZATION OF TETRAETHYL ORTHOSILICATE-BASED DYNAMIC HYDROGELS FOR USE AS REVERSIBLE 3-D CELL CULTURE MATRICES by Stipe, Krisitan
University of Montana 
ScholarWorks at University of Montana 
Graduate Student Theses, Dissertations, & 
Professional Papers Graduate School 
2018 
CHARACTERIZATION OF TETRAETHYL ORTHOSILICATE-BASED 
DYNAMIC HYDROGELS FOR USE AS REVERSIBLE 3-D CELL 
CULTURE MATRICES 
Krisitan Stipe 
University of Montana, Missoula 
Follow this and additional works at: https://scholarworks.umt.edu/etd 
 Part of the Biochemistry, Biophysics, and Structural Biology Commons, Biomedical and Dental 
Materials Commons, Biotechnology Commons, and the Materials Chemistry Commons 
Let us know how access to this document benefits you. 
Recommended Citation 
Stipe, Krisitan, "CHARACTERIZATION OF TETRAETHYL ORTHOSILICATE-BASED DYNAMIC HYDROGELS 
FOR USE AS REVERSIBLE 3-D CELL CULTURE MATRICES" (2018). Graduate Student Theses, Dissertations, 
& Professional Papers. 11121. 
https://scholarworks.umt.edu/etd/11121 
This Thesis is brought to you for free and open access by the Graduate School at ScholarWorks at University of 
Montana. It has been accepted for inclusion in Graduate Student Theses, Dissertations, & Professional Papers by an 
authorized administrator of ScholarWorks at University of Montana. For more information, please contact 
scholarworks@mso.umt.edu. 
i 
 
CHARACTERIZATION OF TETRAETHYL ORTHOSILICATE-BASED DYNAMIC HYDROGELS FOR USE 
AS REVERSIBLE 3-D CELL CULTURE MATRICES 
By 
KRISTIAN TYLER STIPE 
Bachelors of Science in Chemistry, University of Montana, Missoula, Montana, 2015 
 
 
Thesis 
presented in partial fulfillment of the requirements 
for the degree of 
 
Master Interdisciplinary Studies 
in Interdisciplinary Studies 
 
The University of Montana 
Missoula, MT 
 
May 2018 
 
Approved by: 
 
Scott Whittenburg, Dean of The Graduate School 
Graduate School 
 
Christopher Palmer, Chair  
Chemistry and Biochemistry 
 
David Macaluso 
Physics & Astronomy 
 
J.B. Alexander ‘Sandy’ Ross 
Chemistry and Biochemistry 
 
Monica Serban 
Biomedical & Pharmaceutical Sciences 
 
 
 
 
 
 
 
  
ii 
 
Stipe, Kristian, M.I.S., Spring 2018            Interdisciplinary Studies 
 
 
CHARACTERIZATION OF TETRAETHYL ORTHOSILICATE-BASED DYNAMIC HYDROGELS FOR USE 
AS REVERSIBLE 3-D CELL CULTURE MATRICES 
 
Chairperson: Christopher Palmer 
 
Cell culture trends have shifted in recent years towards techniques that allow cell to be grown in 
physiologically representative, three dimensional (3D) environments. In response numerous cell 
culture matrices were developed and commercialized, and while they do provide extracellular 
matrix-like environments for the cells to grow in, they lack reversibility, hindering the recovery of 
cells for downstream analyses and passaging. To address this unmet need of the 3D culture market, 
we sought to develop a cell culture matrix with intrinsic reversibility, based on tetraethyl 
orthosilicate (TEOS), hyaluronic acid, and gelatin. Our results indicate that the generated hydrogels 
are stable under physiological conditions, present unique thixotropic properties, and have the ability 
to transition between liquid and gel states in response to gentle shear, thus imparting reversibility 
to the matrix. However, our tests indicate that the cytocompatibility of the hydrogels present 
challenges as the metabolic activity of encapsulates cell was impacted. Further experimental 
assessments we conducted suggest that these negative cellular effects are associated with the 
nanoparticles formed by the polymerization of TEOS and that these effects can be modulated through 
the addition of high molecular weight polymers such as polyethylene glycol (PEG). 
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Introduction 
Historically, three dimensional (3D) cell cultures have been implemented to study mammalian cells 
in  physiologically representative environments.1–4 The literature includes several studies where 
cells grown in two dimensional (2D) cultures yield irrelevant results for in vivo studies, especially 
in the context of drug screening.1,5–9 Cells found in nature produce extracellular matrices (ECM) 
comprised of proteoglycans, hyaluronic acid, collagen, elastin, other glycosaminoglycans (GAGs), 
and proteins.10,11 Many commercially available 3D cell culture matrices are produced by mimicking 
the physiological ECM.10 One such product, Purecol, consists of 99.9% pure bovine type I collagen.8 
Another product, Matrigel, is composed of a gelatinous protein mixture secreted by Engelbreth-
Holm-Swarm (EHS) mouse sarcoma cells.12 HyStem-C is a third example of a commercially available 
3D cell culture matrix made of in situ crosslinkable thiol-modified hyaluronic acid, thiol-modified 
gelatin, and polyethylene glycol diacrylate (PEGDA).13,14 All three of the aforementioned materials 
are used for 3D culturing for mammalian cells, even though they have different formulations. 
However, they all have the same shortcoming: the need for potentially harmful conditions, such as 
enzymatic digestion or addition of reducing agents, in order to break apart the matrix for recovery 
or analysis of the cells.9,15 
 
This project was aimed at solving the issue of not being able to recover 3D encapsulated cells 
without using potentially harmful conditions. In order to accomplish less harsh recovery, a 
hydrogel made from tetraethyl orthosilicate (TEOS) was used as a base scaffold, and hyaluronic 
acid (HA) and gelatin were included to provide a physiological condition similar to the secreted 
ECM of the fibroblast cells that were studied in the literature.11,13,16,17 TEOS was chosen as a 
hydrogel scaffold for its rheological characteristics, specifically for its thixotropic behavior.18,19 
Thixotropy is the property of a material becoming less viscous when subjected to an applied stress 
and then returning to the original state once the stress is removed.20 This provides the ability to 
separate the hydrogel matrix from the cells simply using a gentle vortexing followed by 
centrifugation.  Once the cells have been pelleted the hydrogel can be removed by simply pouring or 
pipetting away the soft hydrogel.  Gelatin was chosen to be included in the hydrogel for its ability to 
provide cellular attachment sites, which can promote cell proliferation throughout the hydrogel 
itself.21,22 Hyaluronic acid was chosen because it is a natural component of cellular ECM and can 
contribute to cell proliferation and migration.10,23 
 
Project Goals 
The goal of this project is to characterize the individual components of the hyaluronic acid and 
gelatin adducts (HAG) thixotropic hydrogels composed from TEOS and HAG, and then characterize 
and optimize the hydrogel as a cell culture medium.   
Methods 
Carboxymethyl Hyaluronic Acid Modification 
Carboxymethyl hyaluronic acid (CMHA) synthesis was achieved through a heterogeneous phase 
reaction.24 Briefly, 250 mg of hyaluronic acid (HA) was dissolved into 2.5 mL of 45% w/v sodium 
hydroxide (NaOH) and stirred for two hours at room temperature. The viscous solution was 
transferred to a beaker containing 180.75 mL of isopropanol. A chloroacetic acid/isopropanol 
solution was prepared by dissolving 250 mg chloroacetic acid into 6.25 mL isopropanol. The 
solution containing HA and isopropanol was added in the isopropanol/chloroacetic acid mixture for 
1 hour at room temperature. The sample was filtered with a #2 Whatman paper and a Büchner 
funnel. The HA was insoluble during this whole process. The collected CMHA was then dissolved in 
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25 mL of deionized water and the pH of the solution adjusted to ~pH 7.0 using 6M HCL. The 
solution was dialyzed against deionized water for 24 hours with 4 changes of water using dialysis 
cassettes with a molecular weight cutoff of 3500 Da.25 
 
Carboxymethyl Hyaluronic Acid/Gelatin Coupling  
The CMHA and gelatin coupling was performed by dissolving 10 mg of CMHA in 10 mL of 0.1 M 2-
(N-morpholino) ethanesulfonic acid (MES) buffer at pH 4.75 (0.5 mmol CMHA). Then 10 mg gelatin 
(Bloom 75) was added and allowed to dissolve. Next, 2.4 mg 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide HCL (EDC) (0.25 mmol EDC) was added to the solution.  The reaction was stirred for 4 
hours while a pH between 4.75 and pH 6 was maintained (HCl was used for pH adjustment). After 4 
hours the pH was adjusted to pH 8.5 with NaOH, then dialysis of the reaction mixture was 
performed against water in 50,000 Da molecular weight cutoff dialysis tubing. Seven water changes 
over 48 hours were performed. After dialysis was complete the solution was frozen at -80°C for 4 
hours then lyophilized.10,26 This reaction scheme is shown in Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Chemical scheme of the EDC crosslinking process. 
 
Biuret Colorimetric Assay 
The Biuret reagent was used to measure the amount of gelatin present in hyaluronic acid/gelatin 
(HAG) and carboxymethyl hyaluronic acid/gelatin (CMHAG) via a colorimetric assay. The Biuret 
assay is a copper (II) complex that will bind between two peptide bonds to give a colorimetric 
change.  
 
The Biuret reagent was made by dissolving 6.0 g sodium potassium tartrate tetrahydrate in 500 mL 
dH2O. CuSO4 pentahydrate (1.5g) was then added, followed by slow addition of 300 mL of 10% 
(w/v) NaOH. The resulting solution was diluted to 1 liter with dH2O. 
 
Hydrogel Formation 
Hydrogels were formed by first hydrolyzing 2 mL of tetraethyl orthosilicate (TEOS) in 18 mL of 
0.15 M acetic acid, which gives a 1:9 v/v ratio.  The solution was vigorously mixed for 1 hour until a 
homogeneous solution was obtained. The resulting acid-hydrolyzed tetraethyl orthosilicate 
(HTEOS) was used to make hydrogels. Formulations of 1:1 and 1:2 v/v water or phosphate-
buffered saline (PBS) to HTEOS ratios were tested. For hydrogel formation to occur the water or 
PBS and HTEOS mixture was adjusted to ~ pH 2 by using 3 M acetic acid and left to stand for 3 
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hours on the bench. After 3 hours the pH was adjusted to ~pH 8.5 with 1.5 N ammonium hydroxide. 
Gelation of hydrogels was observed within 30 seconds to 30 minutes, depending on the ratio of 
water or PBS to HTEOS used. Hydrogel samples were then left overnight to allow the gel to 
completely form. The hydrolysis reaction scheme is shown in Figure 2. 
 
For CMHA acid crosslinked with gelatin (CMHAG) hydrogels, a solution of CMHAG was dissolved in 
PBS and used in place of regular PBS as described above.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Chemical scheme for hydrolysis of tetraethyl orthosilicate (TEOS). 
 
Cell Assays - Cell Viability and Proliferation/Metabolic Activity 
Primary adult human dermal fibroblasts (HDF) (Lonza) were used to assay the cytocompatibility of 
the TEOS hydrogels. Multiwell (96 or 24 well) plates were coated with 100 mL or 250 mL of 
hydrogel respectively, then seeded with 10,000 cells/well or 20,000 cells/well respectively. The 
cells were cultured in serum-free fibroblast conditioned media (Lonza) and incubated for 24 hours 
at 37°C and 5% CO2 prior to assaying. Cell viability was determined by using a Live/Dead 
cytotoxicity assay kit (ThermoFisher) for mammalian cells. All images for the Live/Dead assay were 
taken on a Leica DMI3000 B brightfield/fluorescent microscope at 10X magnification, unless 
otherwise stated. Cellular proliferation/metabolic activity was quantified with a Cell-Titer 96 
Aqueous One Solution Cell Proliferation Assay (Promega) (MTS assay) and detected via absorption 
measurements at 450 nm on a Molecular Devices FilterMax F5 microplate reader (Molecular 
Devices).  
 
Rheological Characterization 
The rheological properties of all hydrogels were characterized with a Discovery HR2 hybrid 
rheometer (TA Instruments). The tests were conducted within the materials’ pseudo-linear 
viscoelastic range with a 1.00 mm gap, at 20°C, unless otherwise specified. Oscillatory strain 
sweeps for thixotropy investigation were conducted with an 8-mm parallel plate geometry within a 
strain range of 1–250% and an angular frequency of 10 rad/s. The wait time between the cycles 
was 30 seconds. For temperature-dependent hydrogel behavior evaluation, samples were loaded 
onto the Peltier plate and a 20-mm parallel plate geometry (to provide a larger temperature 
exchange surface) was used for characterization. The hydrogel samples were equilibrated to 4°C 
then subjected to a temperature ramp of 2°C/min up to 37°C, at a strain rate of 0.4 % and an 
angular frequency of 10 rad/s. Swelling tests were performed with the 20 mm flat plate geometry 
and an active axial force control of 0.1 N. Hydrogels were loaded onto the Peltier plate and 
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equilibrated at 37°C for 6 min. Phosphate-buffered saline (PBS), pre-warmed to 37°C, was then 
added and the gap distance between the Peltier plate and the 20 mm parallel plate geometry was 
monitored for 30 min post addition. Initial gap heights varied from 1000 to 2000 μm depending on 
sample loading variations.19 
 
Scanning Electron Microscopy (SEM) 
The hydrogel constituent nanoparticles were investigated with a Hitachi S-4700 Field Emission 
Scanning Electron Microscope (Hitachi Instruments). The hydrogel samples were made in 15 mL 
conical tubes, frozen at -80°C for 4 hours, and then lyophilized for 24 hours. The dry particles were 
vortexed to break up nanoparticle aggregates. The dried samples were placed on a conductive 
carbon tab and sputter coated with gold in a Denton Desk V sputter coater (Denton Vacuum). 
Images were taken at 45,000X magnification.  
 
Dynamic Light Scattering (DLS) 
To confirm the nanoparticle size non-gelling hydrolyzed TEOS formulations (1:0.1 v/v 
Water/HTEOS ratio) were investigated at 25°C using a Zetasizer Nano ZS DLS spectrometer 
(Malvern Instruments).  
 
Proton Nuclear Magnetic Resonance (1H-NMR) 
Proton nuclear magnetic resonance (1H-NMR) spectral data were obtained using a Varian INOVA 
400 (400 MHz, Agilent Technologies). All water peaks were set to a reference value of 4.5 ppm. 
Solvents for all samples were either deuterated water (D2O) or deuterated dimethyl sulfoxide 
(DMSO). 
 
Fourier Transform Infrared (FTIR) 
Fourier transform infrared analyses were conducted on a NicoletTM iS5 Spectrometer with iD5 ATR 
accessory from ThermoFisher Scientific. 
Results & Discussion: 
The obtained data are discussed in three individual subsections: the analytical characterization of 
the individual hydrogel constituents, the effects of hydrogel composition on cellular viability, and 
the rheological characterization of hydrogels. The first step was to characterize and quantify the 
amount of hyaluronic acid and gelatin present in the HAG adduct, then to quantify the byproducts of 
TEOS hydrolysis reaction; ethanol and nanoparticles. The second step was to investigate the 
cellular effects of the hydrogels and the cellular interaction mechanisms of HTEOS hydrogel 
components.  The final step was the rheological characterization of the TEOS hydrogel containing 
the HAG component and polyethylene glycol (PEG). 
 
Analytical Characterization of Hydrogels and Constituents 
Carboxymethyl HA 
Proton nuclear magnetic resonance (1H NMR) in deuterated water (D2O) was performed to confirm 
and quantify carboxymethyl modification of HA. The carboxymethyl modification can be observed 
via NMR by monitoring the chemical shift at 3.87 ppm. This chemical shift corresponds to the CH2 
group that was added as part of the chemical modification. Figure 3A shows the NMR spectrogram 
of unmodified HA and Figure 3B shows the NMR spectrogram of CMHA. Evidence of modification 
appears at 3.87 ppm in the modified HA and not in the unmodified HA spectrogram. In addition to 
identification of modification, the degree of modification can be determined by using peak 
5 
 
integration of the NMR spectrograms. The peak at 1.85 ppm corresponds to the CH3 group of the N-
acetyl functional group. The integration of the CH2 group from the carboxymethyl modification can 
be compared to the CH3 group of the N-acetyl functional group in HA to determine modification 
efficiency. When the integration is performed it appears that the modification efficiency is ~40%. 
This corresponds to ~40% of the HA being modified with carboxymethyl functionalities. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 3: 1H NMR of hyaluronic acid (A) and carboxymethyl modified hyaluronic acid (B). The red 
square (-∎) correlates the added CH2 group from the modification to the peak on the NMR. The 
structures of hyaluronic acid and carboxymethyl hyaluronic acid are shown in (C). 
CMHA-Gelatin Crosslinking 
The successful crosslinking of CMHA and gelatin was confirmed by 1H NMR. Figure 4 (A) shows the 
spectrogram of the reaction control, for which CMHA and gelatin were combined under the same 
condition as the crosslinked compound but without EDC, the crosslinking reagent. After the 
purification process no gelatin specific signals were visible in the spectrogram. Figure 4 (B) shows 
the NMR spectrogram of carboxymethyl hyaluronic acid crosslinked to gelatin (CMHAG) in the 
presence of EDC. The end product, after purification, shows NMR resonances at 4.5 ppm and 7.5 
ppm associated with gelatin. Samples were analyzed in deuterated DMSO. 
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 Figure 4: Carboxymethyl hyaluronic acid mixed with gelatin (no crosslinking reagents) (A). 
Crosslinked carboxymethyl hyaluronic acid with gelatin (B) 
Gelatin Quantification in HAG 
The quantification of gelatin in the HAG adduct was determined using a colorimetric biuret assay, 
which binds copper (II) to peptide bonds to produce a colorimetric change. 
 
To construct a gelatin standard curve a 1:1 volumetric ratio of biuret to gelatin solution was used to 
prepare the standard curve. A serial dilution of gelatin was made with concentrations between 4 
mg/mL and 18 mg/mL and the absorbance of each solution at 540 nm was measured with a 
SpectraMax Plus 384 plate reader. 
 
Figure 5: Gelatin standard curved obtained by using the Biuret assay. 
 
Once the standard curve was constructed, known concentrations were used to validate the accuracy 
of the curve. In Table 1 the known concentrations are shown on the left and the concentrations 
calculated using the standard curve are on the right.  
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Known Gelatin conc. 
(mg/mL) 
Calculated Gelatin conc. 
(mg/mL) 
7 7.142 ± 0.004 
13 13.780 ± 0.003 
15 16.144 ± 0.001 
Table 1: Known concentrations of gelatin compared to concentrations calculated by using the 
absorption values and the linear regression line from the standard curve. 
 
Once the standard curve was confirmed to be accurate, samples of HAG adducts were tested to 
determine their gelatin content (Table 2). Specifically, three HAG concentrations were tested (10, 
20, and 40 mg/mL) to determine their gelatin content. A HAG concentration of 10 mg/mL yielded 
4.062 ± 0.002 mg/mL gelatin, a HAG concentration of 20 mg/mL yielded 9.383 ± 0.002 mg/mL 
gelatin, and a HAG concentration of 40 mg/mL yielded 17.347 ± 0.003 mg/mL gelatin. Based on 
these results, the percent concentration of gelatin in the HAG samples were determined to be in the 
40-47% range (Table 2). Pure hyaluronic acid was also tested (data not shown) to ensure that there 
was no background absorbance from the unmodified HA. 
 
HAG 
HAG conc. 
(mg/mL) 
Calculated conc. 
(mg/mL) 
% Gelatin 
10 4.062 ± 0.002 40.62 ± 0.16 
20 9.383 ± 0.002 46.92 ± 0.23 
40 17.347 ± 0.003 43.37 ± 0.31 
Table 2: Measured concentrations and percentages of gelatin in HAG samples at different initial 
concentrations.  
 
When carboxymethyl modified hyaluronic acid/gelatin adduct (CMHAG) was analyzed under the 
same conditions it was shown that more gelatin was bound to CMHAG compared to HAG. This is 
displayed in Table3. 
 
Adduct Conc. 
(mg/mL) 
Gelatin Conc. (mg/mL) % Gelatin 
CMHAG 20 13.53 ±0.0012 67.64  ± 0.12 
HAG 20 9.38 ± 0.0023 46.92  ± 0.23 
Table 3: Comparison of gelatin content in CMHAG and HAG. 
Ethanol Quantification in TEOS Hydrogels 
Ethanol Standard Curve: 
A Fourier transform infrared (FTIR) assay was developed to determine the concentration of ethanol 
in HTEOS gels.  The C-O bond of the ethanol was monitored at 1044 cm-1 to construct the standard 
curve and perform quantitative analyses. The standard curve is presented in Figure 6.  
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Figure 6: Ethanol standard curve based on C-O stretch vibration at 1044 cm-1 using FTIR. 
 
Amount of Ethanol in Hydrogel: 
Once the standard curve was constructed, 4.5 ml of a 1:1 v/v water/HTEOS control hydrogel was 
washed several times until ethanol was no longer detectable via FTIR. The volume used 
corresponds to those used for cell cultures. The amounts from each wash were added up and 
compared to theoretical values in 4.5 mL of hydrogel and 100 L of hydrogel in Table 4. 
 
Parameter determined Measured Theoretical 
Total Volume of EtOH in 4.5 mL of 
hydrogel (L) 
129.7 156.9 
Amount of EtOH in 100of hydrogel (L) 2.88 3.49 
Table 4: Calculated and theoretically determined ethanol volumes in a hydrogel. 
Nanoparticle Characterization 
Quantification of nanoparticles in a 1:1 control hydrogel was done by lyophilizing five replicates of 
100μL of hydrogel and determining the resulting mass of silica nanoparticles. The end result was 
1.648 ± 0.081 mg in 100 μL of hydrogel. The dried samples were analyzed using scanning electron 
microscopy (SEM). Dynamic light scattering (DLS) was performed on a 1:0.1 v/v water/HTEOS 
control hydrogel to determine shape and size of the produced nanoparticles.  
 
Scanning Electron Microscopy (SEM): 
The dried mass of nanoparticles obtained through the lyophilization of hydrogels was analyzed by 
SEM. Figure 7A shows the appearance of hydrolyzed TEOS, with a smoother surface with no major 
signs of nanoparticles. In Figure 7B, a 1:1 control hydrogel is shown, and appears that there are 
nanoparticles smaller than 100 nm. In Figure 7C, a 1:0.1 control hydrogel is shown, and it has a 
much looser network than the 1:1 hydrogel, which is expected, but still has nanoparticles smaller 
than 100 nm. 
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Figure 7: Scanning electron microscope (SEM) images at 45,000X magnification. (A) HTEOS. (B) 1:1 
v/v water/HTEOS hydrogel. (C) 1:0.1 v/v water/HTEOS hydrogel. The scale bar is 1 μm. 
 
Dynamic Light Scattering (DLS): 
The DLS was performed on a 1:0.1 v/v water/HTEOS control hydrogel to allow for slower gelation 
times (Figure 8). At the initial starting point (t=0 minutes), the average diameter of the 
nanoparticles is 22.4 nm, which agrees with the estimation found using SEM. Sample was placed in 
the Zetasizer for analysis immediately after increasing the pH to ~8.5, representing time zero in the 
gelation process. The secondary peak in Figure 8A at 141.6 nm can be correlated to the 
polymerization of the TEOS hydrogel and formation of nanoparticle aggregates. The instrument 
cannot provide accurate particle size after time zero, since the sample becomes a solid hydrogel 
within 30 seconds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Dynamic light scattering analysis of a pre-gelling 1:0.1 v/v water/HTEOS mix. (A) Size 
distribution by intensity of a 1:0.1 control hydrogel. (B) Diameter size distribution of each peak. 
A 
B 
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Hydrogel Composition and Cell Viability 
Published data on TEOS hydrogels indicate that they have cytotoxic effects on primary cells by 
inducing cytoplasmic vacuolation.19 The same study showed that the addition of polyethylene glycol 
(PEG) with molecular weights ranging between 200 and 600 g/mol attenuates the cytotoxic effects 
of TEOS hydrogels. In order to develop a cytocompatible thixotropic 3D culture matrix, it is 
important to identify the source of vacuolation and metabolic activity reduction, and the 
mechanism of PEG-induced cytoprotection.19,27 To this end, the effects of the hydrogel components 
on cell viability were investigated. Based on the well documented cytocompatibility of both HA and 
gelatin, the HAG was excluded from further evaluation.8,11,17 For the TEOS component, it has been 
shown above and in published work that ethanol and silica nanoparticles are released during the 
hydrolysis and polymerization processes.28 Both ethanol and nanoparticles have been reported in 
the literature to have cytotoxic effects.29,27,30 Therefore, for the hydrogels, the individual effect of 
nanoparticles and ethanol on cell viability and metabolic activity needed to be assessed.27,31–33  
Human dermal fibroblasts were exposed to nanoparticles or ethanol at relevant concentrations, 
plated, and incubated for 24 hours before being assayed. These assays determine cell viability, 
proliferation, and activity of the cells under different conditions. Additionally, the mechanism of 
PEG-provided cytoprotection had to be determined19,27,30 
 
Nanoparticles 
The nanoparticles for this assay were suspended in a phosphate-buffered saline (PBS) solution at 
the concentration specific to the measured amount of nanoparticles in a 1:1 v:v hydrogel (1.648 mg 
silica nanoparticles in 100 μL of hydrogel). Figure 9 shows a Live/Dead assay to determine the 
effects of nanoparticles on the cells. In Figure 9A, the control, there appears to be no cell death. In 
the presence of ½ the concentration of nanoparticles found in 100 μL of hydrogel signs of 
vacuolation begin to appear, which can be seen in Figure 9B. Figure 9C shows the normal 
concentration for 100 μL of hydrogel and Figure 9D shows twice the measured amount of 
nanoparticles. The large bright red regions on the images in Figure 9 are large conglomerates of 
nanoparticles, and the smaller red dots are the dead cells.  
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Figure 9: Live/Dead assay for nanoparticles. (A) Control (B) 0.825 mg/mL nanoparticles (½x 
nanoparticles found in a normal hydrogel) (C) 1.65 mg/mL nanoparticles (1x nanoparticles found 
in a normal hydrogel) (D) 3.30 mg/mL nanoparticles (2x nanoparticles found in a normal 
hydrogel). Green represents an intact cell membrane, where red represents a burst cell membrane. 
The scale bar is 200μm. 
 
The results of the MTS assay, a colorimetric assay of metabolic activity of the cells, are presented in 
Figure 10. These results show that the cells have virtually no metabolic activity in the presence of 
the nanoparticles, compared to the control.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: MTS assay on nanoparticle effects. From left to right, control with no nanoparticles, ½ 
the concentration of nanoparticles (0.825 mg/mL), standard concentration of nanoparticles found 
in a 1:1 hydrogel (1.65 mg/mL), and twice the concentration of nanoparticles (3.30 mg/mL). 
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Ethanol 
The effect of ethanol on cell behavior was studied using the same method as the nanoparticles, and 
the volumes used were based on results from Table 4. The results appear to indicate that ethanol, 
even at twice the theoretical volume measured, did not affect cell viability when observed with the 
Live/Dead assay (Figure 11) or the MTS assay (Figure 12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Live/Dead assay for the effects of ethanol. (A) Control (B) 1.75 uL ethanol/mL (½x 
ethanol found in a normal hydrogel) (C) 3.49 uL ethanol/mL (1x ethanol found in a normal 
hydrogel) (D) 6.98 uL ethanol/mL (2x ethanol found in a normal hydrogel). The scale bar is 200 μm. 
 
The MTS for ethanol treatment also supports the results from the Live/Dead. The metabolic activity 
of the cells in the presence of ethanol did not deviate from the control sample. 
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Figure 12: MTS assay on ethanol effects. From left to right: Control, 1.75 uL ethanol/mL (½x 
ethanol found in a normal hydrogel), 3.49 uL ethanol/mL (1x ethanol found in a normal hydrogel), 
and 6.98 uL ethanol/mL (2x ethanol found in a normal hydrogel). 
 
Overall, these results indicate that nanoparticles, but not the ethanol, are responsible for 
vacuolation. The amount of ethanol found in each hydrogel is not sufficient to cause negative effects 
on the cells. Nanoparticles, even at half the concentration found in gels, eliminate the metabolic 
activity of the cells. 
Improving Cell Viability 
Having determined that the nanoparticles are causing vacuolation and reducing metabolic activity 
of cells, the next step is to try to reduce or eliminate these negative effects. Based on previous data 
from the Serban Laboratory and others, it appears that the inclusion of a large molecular weight 
polymer, such as polyethylene glycol, in the thixotropic hydrogels may protect cells and lead to 
improved cell viability.19,27,34  
 
In the current study, inclusion of two PEG polymers of different molecular weights was assessed. 
Incubation studies were performed to determine the mechanism of protection of the cells.27,30  It 
was determined that PEG 600 performed better than PEG 200 as a protecting agent, and that it was 
most effective if the PEG was used to encapsulate the nanoparticles.  
 
Hyaluronic acid gelatin (HAG) adduct was introduced to the PEG 600 hydrogels, and it was found 
that the HAG material containing the highest amount gelatin performed somewhat better than 
samples without gelatin. This effect can be related to the fact that gelatin provides cellular 
attachment sites that encourage cell proliferation through the matrix.22,35  
 
The cell protective effects of PEG were tested as a solution and as a hydrogel. The concentration of 
the PEG solution was mirrored to be the same end concentration of PEG in the hydrogel. In the 
hydrogel a 5%, 12.5%, 25%, and 50% PEG solution was used, then diluted by TEOS and the 
required acid and base to form the hydrogel. Taking this dilution into account, the final PEG 
concentrations in solutions and gels were 1.3%, 3.2%, 6.4%, and 12.8% respectively.   
 
PEG 200: 
In Figure 13 the Live/Dead assay can be seen for the different concentrations of PEG 200. The 1.3% 
and 3.2% PEG solution treated cells do not appear visually different from the control tissue culture 
plate (TCP) cultured cells, whereas 6.4% and 12.8% PEG elicit a rounded, non-specific cellular 
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phenotype. One explanation for the loss of the normal cellular phenotype would be due to the 
viscosity of PEG solution restricting the spindle shaped characteristic. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 13: Live/Dead assay for the effects of PEG 200 in solution. (A) 1.3% PEG 200 (B) 3.2% PEG 
200 (C) 6.4% PEG 200 (D) 12.8% PEG 200 and (E) tissue culture plate (TCP). The scale bar is 200 
μm.  
 
The Live/Dead assay results for PEG 200 TEOS hydrogels are shown in Figure 14. The 
concentration of PEG 200 is the same as the PEG solutions shown in Figure 13. Since the samples 
are now 3D gels the resolution of the images is slightly influenced by the presence of the hydrogels. 
Furthermore, the fact that none of the typical fibroblast morphology is seen is not unexpected as it 
is widely reported in the literature for 3D substrates lacking cell attachment sites, because in a 3D 
environment the cell attachment sites will be different than on a 2D surface.5,8,9,36 This is true for all 
of the hydrogels examined in this study.  The cells plated on the hydrogels appear to maintain an 
intact membrane, as shown in in Figure 14D. However, at 20X magnification of Figure 14D, shown 
in Figure 14E, evidence of vacuolation can be seen in the presence of PEG 200. 
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Figure 14: Live/Dead assay for the effects of PEG 200 in TEOS hydrogel. (A) 1.3% PEG 200 (B) 
3.2% PEG 200 (C) 6.4% PEG 200 (D) 12.8% PEG 200 and (E) 12.8% PEG 200 at 20X magnification, 
instead of 10X. The scale bar is 200μm. 
 
The results are further complemented and corroborated with a cellular metabolic activity assay as 
illustrated in Figure 15.  In the presence of PEG 200 solutions, MTS assay data indicate that there is 
a reduction of metabolic activity as the concentration of PEG increases, compared to the tissue 
culture plate. The PEG 200 TEOS hydrogels results in Figure 15 show virtually no difference 
compared to the control without any PEG 200, regardless of concentration.  
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Figure 15: MTS assay for the effect of PEG 200 solution (top) and PEG 200 hydrogels (bottom) for 
5%, 12.5%, 25%, and 50%, which correspond to the end concentration of 1.3%, 3.2%, 6.4%, and 
12.8% PEG 200. The control sample was TEOS hydrogel with no PEG included, and the last sample 
shown is tissue culture plate (TCP). All samples are normalized to TCP. 
 
PEG 600: 
When treated with PEG 600 and PEG 200, in Live/Dead assays (Figure 16) cells appear to have 
similar phenotypes, except for 6.4% PEG 600 (Figure 16C), where the traditional cellular phenotype 
of fibroblast cells for two dimensions is observed.  
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Figure 16: Live/Dead assay for the effects of PEG 600 in solution. (A) 1.3% PEG 600 (B) 3.2% PEG 
600 (C) 6.4% PEG 600 (D) 12.8% PEG 600 and (E) tissue culture plate (TCP). The scale bar is 200 
μm. 
 
Similar to the PEG 200 hydrogels, the PEG 600 hydrogels (Figure 17) have cells growing on the Z-
axis, which causes some image distortion, as there are cells growing above and below the plane of 
focus and are no longer coplanar. In the PEG 600 hydrogel, there doesn’t appear to be any 
vacuolation readily present.  
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Figure 17: Live/Dead assay for the effects of PEG 600 in TEOS hydrogel. (A) 1.3% PEG 600 (B) 
3.2% PEG 600 (C) 6.4% PEG 600 (D) 12.8% PEG 600. The scale bar is 200 μm. 
 
The PEG 600 solution MTS (Figure 18, left) shows a similar trend as the PEG 200 solution MTS, 
where the metabolic activity of the cells decreased with increasing concentration of PEG 600, 
predominantly at 12.8% PEG 600. The PEG 600 hydrogel MTS (Figure 18, right) shows that, in the 
presence of PEG 600, the fibroblasts had an increased metabolic activity compared to the control 
hydrogel.  
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Figure 18: MTS assay for the effect of PEG 600 solution (top) and PEG 600 hydrogels (bottom) for 
5%, 12.5%, 25%, and 50%, which correspond to the end concentration of 1.3%, 3.2%, 6.4%, and 
12.8% PEG 200. The control sample was TEOS hydrogel with no PEG included, and the last sample 
shown is tissue culture plate (TCP). All samples are normalized to TCP. 
PEG Protection Mechanism 
Having shown that inclusion of PEG 600 eliminates cell vacuolation and increases cell metabolic 
activity in the hydrogels, we investigated the mechanism of cell protection. There were two possible 
mechanisms of action; the PEG could encapsulate the cells themselves, or the PEG could 
encapsulate the nanoparticles responsible for negative cellular effects and vacuolation. To test this 
hypothesis cells were plated with different pre-treatments of PEG 600 50%. All incubations were 
accompanied by a control in PBS instead of PEG. Cells were incubated or washed for 10 minutes on 
the bench, plated on the multiwell plate, and incubated for 24 hours before assays were performed.  
 
Figure 19 shows MTS assay results for different pre-treatment and hydrogel conditions. In the case 
of hydrogel PEG wash, 12.8% PEG 600 solution was introduced into the preformed hydrogel, left to 
incubate for 10 minutes, and then removed. This pretreatment resulted in some cell metabolic 
activity. In the case of Cell PEG wash, the cells were suspended in a 12.8% PEG solution and left to 
incubate for 10 minutes before being re-suspended in cell growth media. This sample showed 
virtually no metabolic activity. The control hydrogel, which is just a TEOS hydrogel with no PEG, 
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shows no metabolic activity. The PEG hydrogel is made under the same conditions as the rest of the 
gels, with a 50% PEG 600 solution in place of water/PBS to form a PEG 600 50% (12.8%) hydrogel. 
The PEG hydrogel sample shows moderate metabolic activity just as in Figure 18 (right). The last 
two samples are controls on tissue culture plate. The first control is plated with the cells that were 
incubated in the 12.8% PEG solution, which is why there is an observed decrease in metabolic 
activity compared to the sample seen in Figure 18 (right). The second control is non-PEG incubated 
cells. Cells that were not incubated in PEG 600 were instead incubated in PBS for the same amount 
of time. 
 
Figure 19: Protection mechanism of PEG on cells and hydrogels based on metabolic activity. From 
left to right samples are as followed: Hydrogel that was washed and incubated in 12.8% PEG 600, 
cells incubated in 12.8% PEG 600 before being seeded on a TEOS hydrogel, TEOS hydrogel with no 
PEG, TEOS hydrogel with 12.8% PEG 600, tissue culture plate (TCP) with cells incubated in 12.8% 
PEG 600, and tissue culture plate (TCP) that had un-incubated cells. 
 
The TEOS hydrogel treatments that showed metabolic activity were those where the hydrogels 
were incubated or formulated with PEG. This supports the conclusion that PEG is actually 
interacting with the nanoparticles in the hydrogel to prevent negative cell effects instead of the cells 
being surrounded by the PEG.27 
CMHAG/PEG Hydrogels 
With the optimal PEG molecular weight, concentration, and mechanism of protection determined, 
hyaluronic acid/gelatin (HAG) adduct was added to the PEG 600 hydrogels to test the material as a 
thixotropic 3-D hydrogel. The Live/Dead assay of 50% (12.8%) PEG 600 TEOS hydrogel with three 
different hyaluronic acid to gelatin ratios, 1:1, 1:0.5, and 1:0, each at three concentrations of 0.5%, 
0.25%, and 0.1%, were tested. Assay results are shown in Figure 20. The distorted images shown in 
Figure 20 can be attributed to the 3D nature of the hydrogel that is allowing for cells to be above 
and below the plane of focus. The 1:0 HAG 0.1% appears to have decreased cell viability. This can be 
attributed to a lower concentration of HA and the absence of gelatin. Gelatin provides cell 
attachment sites, and the lack of binding sites will inhibit cell growth.  
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Figure 20: Live/Dead assay to address the effects of hyaluronic acid/gelatin (HAG) adduct on 50% 
(12.8%) PEG 600 TEOS hydrogels at different ratios of HA to gelatin (left axis) and difference 
concentrations of adduct (top axis). The scale bar is 200 μm. 
 
The MTS assay result of the HAG/PEG/TEOS hydrogels, shown in Figure 21, supports the results 
from the Live/Dead assay. Most of the samples were within error of the control hydrogel with no 
HAG, except for 0.1% 1:0 HAG hydrogel. 
  1
:0
 H
A
G
 
 
 
   
 1
:0
.5
 H
A
G
 
 
 
   
 1
:1
 H
A
G
 
22 
 
Figure 21: MTS of different ratios of hyaluronic acid to gelatin (1:1, 1:0.5, and 1:0) and different 
concentrations of the HAG adduct (0.5%, 0.25%, and 0.1%). 
 
CMHAG/PEG Hydrogel Rheology 
With studies of the hydrogel-induced cellular behavior complete, rheological characterization of the 
CMHAG/TEOS/PEG hydrogel was needed. The effects of PEG addition on hydrogels’ thixotropy, 
temperature stability and swelling effects were studied to test if the addition of PEG changed the 
rheological characteristics of the hydrogel.19 
 
Thixotropy is characterized by the crossing of the storage modulus (G’), which represents the 
“solid” state, and the loss modulus (G’’), which represents the “liquid” state. Once the loss modulus 
is greater than the storage modulus the sample has liquid characteristics. After the sample is in a 
liquid state, to be thixotropic, it must be able to return to the “solid” or hydrogel state, and this is 
achieved by giving the sample a 30 second rest and then running the same experiment. As 
demonstrated in Figure 22, the storage modulus drops below the loss modulus, then returns to its 
original state after the applied force is removed, which is indicative of a thixotropic material. The 
material tested is a 50% (12.8%) PEG 600 TEOS hydrogel with a 0.5% concentration of 1:1 ratio of 
hyaluronic acid to gelatin (1:1 HAG). This sample is the highest concentration of HAG adduct, as 
well as the highest hyaluronic acid to gelatin ratio, making it the most extreme condition, and it still 
maintained the thixotropic characteristic. The fact that this material is thixotropic means that the 
hydrogel could be used to recover cells without the need to enzymatically digest or add reducing 
agents. 
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Figure 22: Thixotropic test, oscillatory strain % vs time of a 50% (12.8%) PEG 600 TEOS hydrogel 
with a 0.5% concentration of 1:1 ratio of hyaluronic acid to gelatin (1:1 HAG)  
 
The next property tested is temperature stability of the hydrogel, because if the sample degrades 
within the working temperature range it would not be useful. The characterization showed that the 
sample was relatively stable, with a less than 1% change in storage modulus over a temperature 
range of 4 to 37°C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23: Temperature dependence, oscillatory strain vs temperature of a 50% (12.8%) PEG 600 
TEOS hydrogel with a 0.5% concentration of 1:1 ratio of hyaluronic acid to gelatin (1:1 HAG) 
 
The final physical characteristic test is if the sample swells in the presence of liquid, specifically 
PBS. The PBS was equilibrated to 37°C prior to the experiment. The hydrogel sample was loaded 
onto the Peltier plate; the upper geometry was lowered and set to maintain an applied force of 
0.1N. Any change in force produced by swelling of the sample would be adjusted for by increasing 
or decreasing the gap the gap between the two plates to maintain a constant applied force. The 
warmed PBS was added at two minutes and the hydrogel sample was submerged. After 7 minutes 
the sample had swollen to its maximum volume, which resulted in a 1.4% change in the gap.  
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Figure 24: Swelling test, gap vs time of a 50% (12.8%) PEG 600 TEOS hydrogel with a 0.5% 
concentration of 1:1 ratio of hyaluronic acid to gelatin (1:1 HAG) 
 
Overall, the physical and viscoelastic characteristics of the CMHAG/PEG/TEOS hydrogels are the 
comparable to the hydrogels without PEG and without CMHAG.19,27 
Conclusion 
This work summarizes the characterization tests performed to address the feasibility of using 
tetraethyl orthosilicate (TEOS) based thixotropic hydrogels as reversible 3D cellular matrices. The 
goal of the project was to supplement existing data from the Serban Laboratory and to gain an 
understanding of the mechanism of TEOS-based hydrogel induced cytotoxicity. It was shown that, 
of the two reaction products of TEOS hydrolysis (ethanol and nanoparticles), the nanoparticles 
were causing cytotoxic effects. PEG was shown to have some protecting effects against the 
vacuolation of cells from nanoparticles created by the hydrogel.19,30,34 The mechanism for 
protection was determined to be facilitated by incubation of the hydrogel itself, not the incubation 
of cells before being added to the hydrogel, indicating that the PEG is most likely coating the 
nanoparticles to prevent vacuolation.  
 
Overall, the acquired results indicate that although the TEOS hydrogels could support cell viability 
and metabolic activity their performance does not compare to the tissue culture plate or to 
commercially available products like HyStem.16,17,37 Cytotoxicity is likely still occurring because the 
PEG does not fully prevent interactions between the nanoparticles and cells.  Since it appears that 
nanoparticles may still be a concern, a new method or a new hydrogel that will not produce 
nanoparticles needs to be considered. 
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Future Experiments 
The data demonstrates that thixotropic hydrogels as a 3D cell culture system have merit based on 
their viscoelastic properties; however, the issue of cytotoxicity needs to be eliminated. The next 
step would be to eliminate nanoparticle formation completely and replace it with an alternative 
material that can form a thixotropic hydrogel but does not form nanoparticles.33,38 For such an 
approach, hyaluronan could be chemically modified with functionalities capable of thixotropy. Two 
possible materials would be N-(6-aminohexyl)aminomethyltriethoxysilane (AAS) and 4-
aminobutyltriethoxysilane (ABS). These materials have a similar structure to TEOS (see Figure 25) 
but have only three hydrolysable ethoxy groups and a fourth, stable pendant group incorporating 
primary amine functionality. This amine group could be used to modify hyaluronic acid with the 
AAS or ABS using the same EDC chemistry that was used to crosslink hyaluronic acid to gelatin.26,39 
Hypothetically, a thixotropic hydrogel could be formed using triethoxy silane-modified hyaluronic 
acid which would be too large to produce nanoparticles that could be internalized by cells.27,40,41 
 
 
 
 
 
 
 
 
 
 
 
Figure 25: Chemical structure of 4-aminobutyltriethoxysilane (ABS) and N-(6-
aminohexy)aminomethyltriethoxyliane (AAS) 
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